about
Expression of dual nucleotides/cysteinyl-leukotrienes receptor GPR17 in early trafficking of cardiac stromal cells after myocardial infarction.Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart diseaseMurine left atrium and left atrial appendage structure and function: echocardiographic and morphologic evaluationEvaluation of Left Ventricle Function by Regional Fractional Area Change (RFAC) in a Mouse Model of Myocardial Infarction Secondary to Valsartan Treatment.Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases.Feasibility of quantitative analysis of regional left ventricular function in the post-infarct mouse by magnetic resonance imaging with retrospective gating.Peroxisome proliferator-activated receptor {alpha} agonism prevents renal damage and the oxidative stress and inflammatory processes affecting the brains of stroke-prone rats.Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases.Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction: comparison with aspirin and rosuvastatin.Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage.Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, prevents hypertensive vascular hypertrophy and fibrosis.Fenofibrate attenuates cardiac and renal alterations in young salt-loaded spontaneously hypertensive stroke-prone rats through mitochondrial protection.A Specific Circulating MicroRNA Cluster Is Associated to Late Differential Cardiac Response to Doxorubicin-Induced CardiotoxicityImpact of BDNF Val66Met Polymorphism on Myocardial Infarction: Exploring the Macrophage Phenotype
P50
Q34336849-23009BE2-4856-46A6-86E5-A1767E368934Q34359022-016AF41E-7CB5-45A1-9498-BCA5096613CAQ35558193-4B370B3D-8ED6-42D4-860F-816008654E59Q35751394-D90DA96C-1EB6-4615-A844-6007FBABFCF9Q38728679-3CD348B3-7A21-4891-A1FD-53C7F00007F4Q39725674-C3E82B50-39AA-4CC0-8CA3-25A0005A8157Q39852189-B30A721B-010F-4D78-9167-7ABCEAE19E2EQ41432422-12A97C3A-DACD-4F2E-BE67-508F82F8621BQ43120732-30063ED1-E7D5-48C2-AD20-62BDEDB78337Q43292243-86F50C61-A2AD-40F4-9050-F7D98D3E72BDQ45145010-861C9AB3-C360-4597-A409-680A3E523313Q47254114-C72A5E1E-21D8-44ED-A2D6-3CAEAB363815Q60907434-991C3A78-6D4C-46E8-95B9-DB44E3395B9EQ94459452-56910B83-2781-43A2-83B0-6247D3D91045
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Laura Castiglioni
@ast
Laura Castiglioni
@en
Laura Castiglioni
@es
Laura Castiglioni
@nl
type
label
Laura Castiglioni
@ast
Laura Castiglioni
@en
Laura Castiglioni
@es
Laura Castiglioni
@nl
prefLabel
Laura Castiglioni
@ast
Laura Castiglioni
@en
Laura Castiglioni
@es
Laura Castiglioni
@nl
P106
P1153
26323506300
P21
P31
P496
0000-0002-0772-3231